Revance to Release Second Quarter 2019 Financial Results on Monday, August 5, 2019
Conference Call Scheduled for Monday, August 5, 2019 at 4:30 p.m. ET NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a…
Pharmaceuticals, Biotechnology and Life Sciences
Conference Call Scheduled for Monday, August 5, 2019 at 4:30 p.m. ET NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee…
Event Brought Together Biopharma Executives and Investors from Around the World for Deal Making and Partnering Opportunities TAIPEI, Taiwan–(BUSINESS WIRE)–One…
PALO ALTO, Calif.–(BUSINESS WIRE)–Science Exchange has announced that its outsourced R&D services platform now integrates with Box’s leading cloud content…
BASEL, Switzerland–(BUSINESS WIRE)–Novaremed AG (Novaremed), a clinical-stage Swiss biopharmaceutical company, announced today that by mutual agreement with the Board of…
ACIP Guidelines Recommend Vaccination for All Longer-Term U.S. Travelers to JE-Endemic Countries; Shorter-Term Travelers Should Also Consider Vaccination GAITHERSBURG, Md.–(BUSINESS…
BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the publication in Nature Biotechnology of a…
RICHMOND, Va.–(BUSINESS WIRE)–The Virginia Bioscience Foundation, a 501(c)(3) not-for profit organization focused on promoting interest in bioscience careers among young…
SEATTLE–(BUSINESS WIRE)–#CardiacImplantMarket–According to Coherent Market Insights, the global cardiac implant market was valued at US$ 34,783.4 million in 2018, and…
NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced that the European Commission (EC) has granted unconditional approval of Bristol-Myers…